These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 23351929)
1. Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis. Nikfar S; Rahimi R; Hendoiee N; Abdollahi M Daru; 2012 Nov; 20(1):75. PubMed ID: 23351929 [TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Rahimi R; Nikfar S; Abdollahi M Reprod Toxicol; 2006 Nov; 22(4):571-5. PubMed ID: 16720091 [TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277 [TBL] [Abstract][Full Text] [Related]
4. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971 [TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses. Uguz F Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713 [No Abstract] [Full Text] [Related]
6. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641 [TBL] [Abstract][Full Text] [Related]
7. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902 [TBL] [Abstract][Full Text] [Related]
8. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Womersley K; Ripullone K; Agius M Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
10. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378 [TBL] [Abstract][Full Text] [Related]
12. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials. Guo S; Chen L; Cheng S; Xu H Medicine (Baltimore); 2019 May; 98(22):e15786. PubMed ID: 31145302 [TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758 [TBL] [Abstract][Full Text] [Related]
14. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients. Shih YC; Bekele NB; Xu Y Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806 [TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews. Ghaffari Darab M; Hedayati A; Khorasani E; Bayati M; Keshavarz K Int J Psychiatry Clin Pract; 2020 Nov; 24(4):357-370. PubMed ID: 32667275 [TBL] [Abstract][Full Text] [Related]
16. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations. Myles N; Newall H; Ward H; Large M Aust N Z J Psychiatry; 2013 Nov; 47(11):1002-12. PubMed ID: 23761574 [TBL] [Abstract][Full Text] [Related]